Evidence map›Paper›PMID 35432942›Full record

ArticleRSC advances2022

Cell penetrating peptide decorated magnetic porous silicon nanorods for glioblastoma therapy and imaging.

Arnaud Chaix, Audrey Griveau, Thomas Defforge, Virginie Grimal, Brice Le Borgne, Gaël Gautier, Joël Eyer

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Nanomedicine for Glioblastoma Therapy: Novel Insights and Future Perspectives.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Arnaud ChaixGREMAN UMR-CNRS 7347, INSA Centre Val de Loire, Université de Tours Tours France gael.gautier@univ-tours.fr.ORCID https://orcid.org/0000-0003-4561-7031
Audrey GriveauMINT, INSERM, CNRS, SFR-ICAT, UNIV Angers 49000 Angers France joel.eyer@univ-angers.fr.
Thomas DefforgeGREMAN UMR-CNRS 7347, INSA Centre Val de Loire, Université de Tours Tours France gael.gautier@univ-tours.fr.
Virginie GrimalGREMAN UMR-CNRS 7347, INSA Centre Val de Loire, Université de Tours Tours France gael.gautier@univ-tours.fr.
Brice Le BorgneGREMAN UMR-CNRS 7347, INSA Centre Val de Loire, Université de Tours Tours France gael.gautier@univ-tours.fr.
Gaël GautierGREMAN UMR-CNRS 7347, INSA Centre Val de Loire, Université de Tours Tours France gael.gautier@univ-tours.fr.
Joël EyerMINT, INSERM, CNRS, SFR-ICAT, UNIV Angers 49000 Angers France joel.eyer@univ-angers.fr.
Université de Tours · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma multiforme (GBM) is the most malignant primary brain tumor of the central nervous system. Despite advances in therapy, it remains largely untreatable, in part due to the low permeability of chemotherapeutic drugs across the blood-brain barrier (BBB) which significantly compromises their effectiveness. To circumvent the lack of drug efficiency, we designed multifunctional nanoparticles based on porous silicon. Herein, we propose an innovative synthesis technique for porous silicon nanorods (pSiNRs) with three-dimensional (3D) shape-controlled nanostructure. In order to achieve an efficient administration and improved treatment against GBM cells, a porous silicon nanoplatform is designed with magnetic guidance, fluorescence tracking and a cell-penetrating peptide (CPP). A NeuroFilament Light (NFL) subunit derived 24 amino acid tubulin binding site peptide called NFL-TBS.40-63 peptide or NFL-peptide was reported to preferentially target human GBM cells compared to healthy cells. Motivated by this approach, we investigated the use of magnetic-pSiNRs covered with superparamagnetic iron oxide nanoparticles (SPIONs) for magnetic guidance, then decorated with the NFL-peptide to facilitate targeting and enhance internalization into human GBM cells. Unexpectedly, under confocal microscope imaging, the internalized multifunctional nanoparticles in GBM cells induce a remarkable exaltation of green fluorescence instead of the red native fluorescence from the dye due to a possible Förster resonance energy transfer (FRET). In addition, we showed that the uptake of NFL-peptide decorated magnetic-pSiNRs was preferential towards human GBM cells. This study presents the fabrication of magnetic-pSiNRs decorated with the NFL-peptide, which act as a remarkable candidate to treat brain tumors. This is supported by

Identifiers

PMID35432942
PMCPMC9008514
OpenAlexW4224228085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.